Stock Track | Tempus AI Soars 5.01% Intraday as Median Technologies Partnership with Canon Highlights AI Healthcare Ties

Stock Track03:40

Tempus AI (TEM) shares surged 5.01% during intraday trading on Thursday, as the medical AI company benefited from positive sentiment surrounding a new partnership in the diagnostic AI space.

The rally was fueled by an announcement from Median Technologies, which revealed a global commercialization agreement with Canon Medical Systems’ Olea Medical unit for its eyonis LCS lung cancer screening software. The news highlighted Median’s multi-channel go-to-market strategy, which notably includes an earlier strategic tie-up with Tempus AI. Investors viewed the expanding ecosystem of AI-driven diagnostics as a strong validation of the sector, lifting shares of Tempus AI in sympathy with the broader industry momentum.

The movement reflects growing confidence in collaborative efforts within the medical AI landscape, as companies like Tempus AI continue to form key alliances to advance precision medicine and diagnostics.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1126339393?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-07-31 03:40","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1126339393","market":"us","top_or_hot":-1,"title":"Stock Track | Tempus AI Soars 5.01% Intraday as Median Technologies Partnership with Canon Highlights AI Healthcare Ties","media":"Stock Track","content":"<p>Tempus AI (TEM) shares surged 5.01% during intraday trading on Thursday, as the medical AI company benefited from positive sentiment surrounding a new partnership in the diagnostic AI space.</p><p>The rally was fueled by an announcement from Median Technologies, which revealed a global commercialization agreement with Canon Medical Systems’ Olea Medical unit for its eyonis LCS lung cancer screening software. The news highlighted Median’s multi-channel go-to-market strategy, which notably includes an earlier strategic tie-up with Tempus AI. Investors viewed the expanding ecosystem of AI-driven diagnostics as a strong validation of the sector, lifting shares of Tempus AI in sympathy with the broader industry momentum.</p><p>The movement reflects growing confidence in collaborative efforts within the medical AI landscape, as companies like Tempus AI continue to form key alliances to advance precision medicine and diagnostics.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Tempus AI Soars 5.01% Intraday as Median Technologies Partnership with Canon Highlights AI Healthcare Ties</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Tempus AI Soars 5.01% Intraday as Median Technologies Partnership with Canon Highlights AI Healthcare Ties\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-07-31 03:40</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Tempus AI (TEM) shares surged 5.01% during intraday trading on Thursday, as the medical AI company benefited from positive sentiment surrounding a new partnership in the diagnostic AI space.</p><p>The rally was fueled by an announcement from Median Technologies, which revealed a global commercialization agreement with Canon Medical Systems’ Olea Medical unit for its eyonis LCS lung cancer screening software. The news highlighted Median’s multi-channel go-to-market strategy, which notably includes an earlier strategic tie-up with Tempus AI. Investors viewed the expanding ecosystem of AI-driven diagnostics as a strong validation of the sector, lifting shares of Tempus AI in sympathy with the broader industry momentum.</p><p>The movement reflects growing confidence in collaborative efforts within the medical AI landscape, as companies like Tempus AI continue to form key alliances to advance precision medicine and diagnostics.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"TEM","symbol_name":"Tempus AI","start_time":0,"source_url":"","article_id":"1126339393","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1126339393","pubTimestamp":1785440424,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Tempus AI (TEM) shares surged 5.01% during intraday trading on Thursday, as the medical AI company benefited from positive sentiment surrounding a new partnership in the diagnostic AI space.The rally...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"TEM":"Tempus AI"},"translate_title":"股票跟踪 | Median Technologies 与佳能的合作伙伴关系凸显人工智能医疗保健关系，腾邦人工智能盘中飙升 5.01%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"TEM":1},"content_text":"Tempus AI (TEM) shares surged 5.01% during intraday trading on Thursday, as the medical AI company benefited from positive sentiment surrounding a new partnership in the diagnostic AI space.The rally was fueled by an announcement from Median Technologies, which revealed a global commercialization agreement with Canon Medical Systems’ Olea Medical unit for its eyonis LCS lung cancer screening software. The news highlighted Median’s multi-channel go-to-market strategy, which notably includes an earlier strategic tie-up with Tempus AI. Investors viewed the expanding ecosystem of AI-driven diagnostics as a strong validation of the sector, lifting shares of Tempus AI in sympathy with the broader industry momentum.The movement reflects growing confidence in collaborative efforts within the medical AI landscape, as companies like Tempus AI continue to form key alliances to advance precision medicine and diagnostics.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.46.0","shortVersion":"4.46.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1126339393","isCrawlerRequest":true}